CARA in equilibrium Giá xuống

Cara Therapeutics, Inc.NASDAQ

Mô tả

⋅ 10 Th09 2019 06:51

Initial spike in volume was caused by fast track and phase 3 news. Nothing to drive the price at the moment. My best best is that we'll see CARA retest $19.65 within a week or so.

Thêm nữa